Author

Erin E. Carlson

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0000-0001-5988-0135

Observed ORCID: 0000-0001-5988-0135

OpenAlex ID: A5003754718

Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2023 · Daniela L. Stan, Julian O. Kim, et al. · Cancer Prevention Research · 4

Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer

2026 · Khalid Jazieh, Erin E. Carlson, et al. · PLoS ONE · 2

Clinical impact of integrating polygenic risk scores with breast cancer risk assessment models: Results from the prospective multisite GENRE-2 clinical trial.

2025 · Siddhartha Yadav, Sandhya Pruthi, et al. · Journal of Clinical Oncology · 2

Supplemental Materials and Methods 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Supplemental Figure 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Supplemental Materials and Methods 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Data from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Data from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Supplemental Figure 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

2024 · Daniela L. Stan, Julian O. Kim, et al.

Works count: 9

Citation count: 8

H-index: 2

I10-index: